Catalyst Biosciences Inc
NASDAQ:CBIO 3:32:27 PM EDT
Earnings Announcements
Catalyst Biosciences Posts Quarterly Loss Per Share $0.65
Published: 03/31/2022 12:52 GMT
Catalyst Biosciences Inc (CBIO) - Catalyst Biosciences Reports Fourth Quarter and Year-end 2021 Operating & Financial Results and Provides a Corporate Update.
Catalyst Biosciences Inc - Qtrly Loss per Share $0.65.
Catalyst Biosciences Inc - Cash, Cash Equivalents, And, Investments, As of December 31, 2021, Were $46.9 Million.
Catalyst Biosciences Inc - Qtrly Loss per Share $0.65.
Catalyst Biosciences Inc - Cash, Cash Equivalents, And, Investments, As of December 31, 2021, Were $46.9 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.30
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.25
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.30
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.25
More details on our Analysts Page.